𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double-blind placebo-controlled study

✍ Scribed by S. P. Jørgensen; J. Agnholt; H. Glerup; S. Lyhne; G. E. Villadsen; C. L. Hvas; L. E. Bartels; J. Kelsen; L. A. Christensen; J. F. Dahlerup


Book ID
108605977
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
201 KB
Volume
32
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


A randomized, double-blind, placebo-cont
✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des

A randomized, double-blind, placebo-cont
✍ Kitty K. Wong; Jane E. Alty; Amanda G. Goy; Sanjay Raghav; David C. Reutens; Pet 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

## Abstract ## Background: This randomized double blind, placebo‐controlled crossover study investigated the antidyskinetic effects of levetiracetam in Parkinson's disease. ## Methods: Sixteen participants with levodopa‐induced dyskinesia were enrolled. Hourly videotaped dyskinesia assessments s